| 000 | 00869nam a2200229Ia 4500 | ||
|---|---|---|---|
| 008 | 170220s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a978-1-4939-2316-8 | ||
| 022 | _a2210-738X | ||
| 040 | _aNISER LIBRARY | ||
| 041 | _aEnglish/International | ||
| 100 | _aFeroz Jameel, Susan Hershenson, Mansoor A. Khan, Sheryl Martin-Moe | ||
| 245 | _aQuality by Design for Biopharmaceutical Drug Product Development | ||
| 260 |
_c2015 _bSpringer New York |
||
| 300 | _bContributed volume | ||
| 440 |
_aAAPS Advances in the Pharmaceutical Sciences Series _n18 |
||
| 650 | _aBiomedical and Life Sciences | ||
| 650 | _aPharmacology/Toxicology; Biomedicine, general | ||
| 710 | _aSpringer Science+Business Media, LLC | ||
| 856 | _uhttp://dx.doi.org/10.1007/978-1-4939-2316-8 | ||
| 856 | _uhttp://link.springer.com/openurl?genre=book&isbn=978-1-4939-2315-1 | ||
| 942 | _cEB | ||
| 999 |
_c27992 _d27992 |
||